SCPH Live signaler | Maksimer profitt med Getagraph.com

SELG 108093 min ago

@ $5.41

Utstedt: 14 feb 2024 @ 15:30

Avkastning: -13.70%

Forrige signal: feb 12 - 18:38

Forrige signal: Kjøp

Avkastning: -1.81 %

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 18:00):

Stats
Dagens volum	63 066.00
Gjennomsnittsvolum	220 659
Markedsverdi	168.32M
EPS	$0 ( 2024-03-13 )
Neste inntjeningsdato	( $-0.450 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.29
ATR14	$0.0170 (0.36%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-29	Tucker John H	Buy	56 025	Stock Option (right to buy)
2024-01-18	Nokes Rachael	Buy	62 755	Stock Option (right to buy)
2024-01-18	Nokes Rachael	Buy	41 840	Common Stock
2024-01-18	Tucker John H	Buy	113 560	Common Stock
2024-01-18	Tucker John H	Buy	170 340	Stock Option (right to buy)

INSIDER POWER
40.38
Last 97 transactions
Buy: 5 205 058 \| Sell: 2 188 570

Volum Korrelasjon

Lang: 0.35 (neutral)

Kort: -0.66 (moderate negative)

Signal:(56.018) Neutral

scPharmaceuticals Inc Korrelasjon

10 Mest positive korrelasjoner
LWAC	0.907
SRAC	0.866
TBBK	0.852
NETE	0.829
HUBG	0.827
MMAC	0.816
SRAD	0.811
TWOU	0.809
MRTN	0.807
NXPI	0.804

10 Mest negative korrelasjoner
SVAC	-0.875
MTSL	-0.822
EGRX	-0.817
PAIC	-0.808

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

scPharmaceuticals Inc Korrelasjon - Valuta/Råvare

-0.08
( neutral )

-0.39
( neutral )

0.00
( neutral )

0.27
( neutral )

0.78
( moderate )

0.59
( weak )

scPharmaceuticals Inc Økonomi

Annual	2023
Omsetning:	$13.59M
Bruttogevinst:	$9.78M (71.96 %)
EPS:	$-1.420

FY	2023
Omsetning:	$13.59M
Bruttogevinst:	$9.78M (71.96 %)
EPS:	$-1.420

FY	2022
Omsetning:	$0
Bruttogevinst:	$-468 000 (0.00 %)
EPS:	$-1.320

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.020

Financial Reports:

No articles found.

scPharmaceuticals Inc

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.